Showing results (1-10 of 671) with videos related to
Sort By:
Pageof 68
Gene Therapy|May 29, 2002
Genome medicine: gene therapy for the millennium, 30 September-3 October 2001, Rome, ItalyD C Gruenert, G Novelli, B Dallapiccola, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragmentsA Colosimo, K K Goncz, G Novelli, et al.International Journal of Clinical & Laboratory Research|January 1, 1996
Detection of eight beta-thalassemia mutations using a DNA enzyme immunoassayA Colosimo, G Novelli, A Cavicchini, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Plasmid DNA and low-frequency electromagnetic fieldsL D'Agruma, A Colosimo, U Angeloni, et al.Gene Therapy|June 27, 2001
Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHRK K Goncz, A Colosimo, B Dallapiccola, et al.Annales De Genetique|January 1, 1988
Gene dosage studies regionally assign the phosphoserine phosphatase gene to 7p15.1 or 2G Novelli, B DallapiccolaBiochemistry and Molecular Biology International|October 27, 2009
Recombinant CTFR detection in CF tracheal epithelial cells following in vitro liposomeme-mediated gene transferA Colosimo, S Scarpino, F Sangiuolo, et al.Biochemical and Biophysical Research Communications|November 30, 1993
Human elongation factor EF-1 beta: cloning and characterization of the EF1 beta 5a gene and assignment of EF-1 beta isoforms to chromosomes 2,5,15 and XA Pizzuti, M Gennarelli, G Novelli, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
The link between cytogenetics and mendelismB Dallapiccola, R Mingarelli, G NovelliHuman Genetics|May 1, 1988
Deletion 2q31.3----2q33.3: gene dosage effect of ribulose 5-phosphate 3-epimeraseB Dallapiccola, G Novelli, A GiannottiPageof 68